Inhaled human insulin (Exubera®): clinical profile and patient considerations

References

• American Diabetes AssociationDiabetes Care199821Consensus Development Conference on the diagnosis of coronary heart disease in people with diabetes10-11 February 1998Miami, Florida155199727908
   PubMedGoogle Scholar
• BarnettAHDreyerMLangePAn open, randomized, parallel group study to compare the efficacy and safety profile of inhaled human insulin (Exubera®) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylureaDiabetes Care2006a291282716732009
   PubMed Web of Science ®Google Scholar
• BarnettAHDreyerMLangePAn open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metforminDiabetes Care20062918182516873786
   PubMed Web of Science ®Google Scholar
• BeckerRHAShaSFrickADThe effect of smoking cessation and subsequent resumption on absorption of inhaled insulinDiabetes Care2006292778216443873
   PubMed Web of Science ®Google Scholar
• BrownJBNicholsGASlow response to loss of glycemic control in type 2 diabetes mellitusAm J Manag Care20039213712643338
   PubMed Web of Science ®Google Scholar
• CampbellIWNeed for intensive, early glycaemic control in patients with type 2 diabetesBr J Cardiol2000762531
   Google Scholar
• CappelleriJCCefaluWTRosenstockJKouridesIAGerberRATreatment satisfaction with inhaled insulin in patients with type 2 diabetes: a randomized controlled trialClin Ther2002245526412017400
   PubMed Web of Science ®Google Scholar
• CefaluWTInhaled insulin: a proof-of-concept studyAnn Intern Med2001134795611329241
   PubMed Web of Science ®Google Scholar
• CefaluWTSkylerJSKouridesIAInhaled human insulin treatment in patients with type 2 diabetes mellitusAnn Intern Med2001134203711177333
   PubMed Web of Science ®Google Scholar
• CerielloACavarapeAMartinelliLThe post-prandial state in type 2 diabetes and endothelial dysfunction: effects of insulin aspartDiabet Med200421171514984453
   PubMed Web of Science ®Google Scholar
• CiofettaMLalliCDel SindacoPContribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtimeDiabetes Care19992279580010332684
   PubMed Web of Science ®Google Scholar
• CookMNGirmanCJSteinPPGlycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetesDiabetes Care200528995100015855556
   PubMed Web of Science ®Google Scholar
• DCCTThe effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research GroupN Engl J Med1993329977868366922
   PubMed Web of Science ®Google Scholar
• DCCT/EDICEffect of intensive therapy on the microvascular complications of type 1 diabetes mellitusJAMA20022872563912020338
   PubMed Web of Science ®Google Scholar
• Del PratoSFeltonA-MMunroNImproving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goalInt J Clin Pract20055913455516236091
   PubMed Web of Science ®Google Scholar
• Del SindacoPCiofettaMLalliCUse of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-mealDiabet Med1998155926009686700
   PubMed Web of Science ®Google Scholar
• DreyerMfor the Exubera® Phase III Study GroupEfficacy and two-year pulmonary safety of inhaled insulin as adjunctive therapy with metformin or glibenclamide in type 2 diabetes patients poorly controlled with oral monotherapy [abstract]Diabetologia200447Suppl 1A44
   Google Scholar
• DumasREnglandRDRieseRJExubera® is well tolerated and achieves tight glycemic control in patients with type 1 diabetes [abstract]Diabetes200554Suppl 1A87
   Google Scholar
• EspositoKGiuglianoDNappoFRegression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitusCirculation2004110214915197140
   PubMed Web of Science ®Google Scholar
• FinebergSEKawabataTFinco-KentDAntibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trialEndocrinol Metab200590328794
   Google Scholar
• FreemantleNBlondeLDuhotDAvailability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetesDiabetes Care200528427815677807
   PubMed Web of Science ®Google Scholar
• FunnellMMKrugerDFSpencerMSelf-management support for insulin therapy in type 2 diabetesDiabetes Educ2004302748015095517
   PubMed Web of Science ®Google Scholar
• GerberRACappelleriJCKouridesIAGelfandRATreatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trialDiabetes Care2001241556911522698
   PubMed Web of Science ®Google Scholar
• GoldfineABGoldfineHLCardiovascular disease in the diabetic patientCirculation2003107e141612538441
   PubMed Web of Science ®Google Scholar
• GungorNArslanianSPathophysiology of type 2 diabetes mellitus in children and adolescents: treatment implicationsTreat Endocrinol200213597115832489
   PubMedGoogle Scholar
• HauberABJohnsonFRSauriolLRisking health to avoid injections: preferences of Canadians with type 2 diabetesDiabetes Care2005282243516123499
   PubMed Web of Science ®Google Scholar
• HaywardRAManningWGKaplanSHStarting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilizationJAMA1997278166399388085
   PubMed Web of Science ®Google Scholar
• HeinemannLOvercoming obstacles: new management optionsEur J Endocrinol2004151Suppl 2T23T715487981
   PubMedGoogle Scholar
• HenryRMudaliarSFryburgDAWithin-subject variability of inhaled insulin (Exubera®) versus subcutaneous regular insulin in elderly obese patients with type 2 diabetes mellitus [abstract]Diabetes200352Suppl 1A105
   Google Scholar
• HollanderPABlondeLRoweREfficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetesDiabetes Care20042723566215451900
   PubMed Web of Science ®Google Scholar
• HuntLMValenzuelaMAPughJANIDDM patients’ fears and hopes about insulin therapy: the basis of patient reluctanceDiabetes Care19972029289051375
   PubMed Web of Science ®Google Scholar
• KhawK-TWarehamNBinghamSAssociation of hemoglobin 1c with cardiovascular disease and mortality in adults: the European Prospective Investigation into Cancer in NorfolkAnn Intern Med20041414132015381514
   PubMed Web of Science ®Google Scholar
• KoroCEBowlinSJBourgeoisNGlycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetesDiabetes Care200427172014693960
   PubMed Web of Science ®Google Scholar
• KorytkowskiMWhen oral agents fail: practical barriers to starting insulinInt J Obes200226Suppl 3S18S24
   PubMed Web of Science ®Google Scholar
• LazarHLChipkinSRFitzgeraldCATight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic eventsCirculation2004109149750215006999
   PubMed Web of Science ®Google Scholar
• LeiterLACerielloADavidsonJAPostprandial glucose regulation: new data and new implicationsClin Ther200527Suppl BS42S5616519037
   PubMed Web of Science ®Google Scholar
• LieblAMataMEschwegeEEvaluation of risk factors for development of complications in type II diabetes in EuropeDiabetologia200245S23S2812136408
   PubMed Web of Science ®Google Scholar
• MalmbergKProspective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study GroupBr Med J1997314151259169397
   PubMed Web of Science ®Google Scholar
• MaloneJKBeattieSDCampaigneBNTherapy after single oral agent failure: adding a second oral agent or an insulin mixture?Diabetes Res Clin Pract2003621879514625133
   PubMed Web of Science ®Google Scholar
• MalmbergKNorhammarAWedelHGlycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) StudyCirculation19999926263210338454
   PubMed Web of Science ®Google Scholar
• MudaliarSHenryRRCombination therapy for type 2 diabetesEndocr Pract199952081915251678
   PubMedGoogle Scholar
• NathanDMClinical practice. Initial management of glycemia in type 2 diabetes mellitusN Engl J Med20023471342912397193
   PubMed Web of Science ®Google Scholar
• OdegardPSCapocciaKLInhaled insulin: ExuberaAnn Pharmacother2005398435315827072
   PubMed Web of Science ®Google Scholar
• PattonJSBukarJGEldonMAClinical pharmacokinetics and pharmacodynamics of inhaled insulinClin Pharmacokinet20044378180115355125
   PubMed Web of Science ®Google Scholar
• PolonskyWHFisherLGuzmanSPsychological insulin resistance in patients with type 2 diabetesDiabetes Care2005282543516186296
   PubMed Web of Science ®Google Scholar
• QuattrinTBelangerABohannonNJVEfficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetesDiabetes Care2004272622715504996
   PubMed Web of Science ®Google Scholar
• RaveKBottSHeinemannLTime-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulinDiabetes Care20052810778215855570
   PubMed Web of Science ®Google Scholar
• ReichardPBerglundBBritzAIntensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 yearsJ Intern Med199123010181865159
   PubMed Web of Science ®Google Scholar
• RiddleMCThe underuse of insulin therapy in North AmericaDiabetes Metab Res Rev200218Suppl 3S42S4912324985
   PubMed Web of Science ®Google Scholar
• RieseRJTeeterJGEnglandRDInhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus [abstract]Eur Respir J200526Suppl 49582S
   Google Scholar
• RosenstockJCappelleriJCBolinderBGerberRAPatient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetesDiabetes Care20042713182315161782
   PubMed Web of Science ®Google Scholar
• RosenstockJZinmanBMurphyLJInhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetesAnn Intern Med20051435495816230721
   PubMed Web of Science ®Google Scholar
• RoylePWaughNMcAuleyLInhaled insulin in diabetes mellitusCochrane Database Syst Rev2003 CD003890
   Google Scholar
• ShichiriMKishikawaHOhkuboYLong-term results of the Kumamoto Study on Optimal Diabetes Control in type 2 diabetic patientsDiabetes Care200023Suppl 2B21910860187
   PubMed Web of Science ®Google Scholar
• SimonsonDCHayesJFTurnerRRTreatment satisfaction and preferences in type 2 diabetes: a randomized trial of oral agents vs. inhaled insulin [abstract]Diabetes200150Suppl 2A131
   PubMedGoogle Scholar
• SkylerJSCefaluWTKouridesIAEfficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept studyLancet2001357331511210993
   PubMed Web of Science ®Google Scholar
• SkylerJfor the Exubera® Phase II Study GroupSustained long-term efficacy and safety of inhaled insulin after 4 years of continuous therapy [abstract]Diabetologia200447Suppl 1A311
   Google Scholar
• SkylerJSWeinstockRSRaskinPUse of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjectsDiabetes Care2005281630515983312
   PubMed Web of Science ®Google Scholar
• StrattonIMAdlerAINeilHAWAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBr Med J20003214051210938048
   PubMed Web of Science ®Google Scholar
• TestaMAImproving diabetes therapy: improving satisfactionDiabetes Voice200348235
   Google Scholar
• TurnerRCCullCAFrighiVGlycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)JAMA199928120051210359389
   PubMed Web of Science ®Google Scholar
• UKPDS GroupUK Prospective Diabetes Study 17: A nine-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitusAnn Intern Med1996124136458554206
   PubMed Web of Science ®Google Scholar
• UKPDS GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet1998352837539742976
   PubMed Web of Science ®Google Scholar
• Van den BergheGWoutersPWeekersFIntensive insulin therapy in critically ill patientsN Engl J Med200134513596711794168
   PubMed Web of Science ®Google Scholar
• WeissSRChengS-LKouridesIAInhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agentsArch Intern Med200316322778214581245
   PubMed Web of Science ®Google Scholar
• [WHO]World Health Organization [online] Accessed 28 February 2006. URL: http://www.who.int/diabetes/facts/world_figures/en
   Google Scholar
• WrightABurdenACFPaiseyRBfor the UK Prospective Diabetes Study GroupSulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)Diabetes Care200225330611815505
   PubMed Web of Science ®Google Scholar
• ZambaniniANewsonRBMaiseyMInjection related anxiety in insulin-treated diabetesDiab Res Clin Pract19994623946
   PubMed Web of Science ®Google Scholar